Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions
about
Ameliorative effect of fisetin on cisplatin-induced nephrotoxicity in rats via modulation of NF-κB activation and antioxidant defenceCancer drug resistance: redox resetting renders a wayCancer metabolism and oxidative stress: Insights into carcinogenesis and chemotherapy via the non-dihydrofolate reductase effects of methotrexateOxidative Stress Resistance in Metastatic Prostate Cancer: Renewal by Self-EatingMitochondrial DNA damage induced autophagy, cell death, and diseaseROS homeostasis and metabolism: a dangerous liason in cancer cellsAn integrated view of cisplatin-induced nephrotoxicity and ototoxicityReactive oxygen species a double-edged sword for mesotheliomaVitamin D derivatives enhance cytotoxic effects of H2O2 or cisplatin on human keratinocytesBaicalein, a Bioflavonoid, Prevents Cisplatin-Induced Acute Kidney Injury by Up-Regulating Antioxidant Defenses and Down-Regulating the MAPKs and NF-κB PathwaysMechanistic Nanotherapeutic Approach Based on siRNA-Mediated DJ-1 Protein Suppression for Platinum-Resistant Ovarian CancerDrp1-dependent mitophagy protects against cisplatin-induced apoptosis of renal tubular epithelial cells by improving mitochondrial function.Tempol, a superoxide dismutase mimetic agent, ameliorates cisplatin-induced nephrotoxicity through alleviation of mitochondrial dysfunction in miceNephroprotective effect of gelsemine against cisplatin-induced toxicity is mediated via attenuation of oxidative stress.Bisdemethoxycurcumin attenuates gastric adenocarcinoma growth by inducing mitochondrial dysfunction.Mitochondria-targeting particles.Inactivation of a common OGG1 variant by TNF-alpha in mammalian cells.SOD2 rs4880 CT/CC genotype predicts poor survival for Chinese gastric cancer patients received platinum and fluorouracil based adjuvant chemotherapy.Bcl2 inhibition of mitochondrial DNA repair.Inhibition of Autophagy Potentiated the Antitumor Effect of Nedaplatin in Cisplatin-Resistant Nasopharyngeal Carcinoma CellsCisplatin Nephrotoxicity and Longitudinal Growth in Children With Solid Tumors: A Retrospective Cohort StudyAngiotensin II type 1 receptor blockers increase tolerance of cells to copper and cisplatin.Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2HPV16 E6 and E7 proteins induce a chronic oxidative stress response via NOX2 that causes genomic instability and increased susceptibility to DNA damage in head and neck cancer cells.ATR-101 disrupts mitochondrial functions in adrenocortical carcinoma cells and in vivo.Failure of Elevating Calcium Induces Oxidative Stress Tolerance and Imparts Cisplatin Resistance in Ovarian Cancer Cells.Cisplatin induces HepG2 cell cycle arrest through targeting specific long noncoding RNAs and the p53 signaling pathwayRegulation of multidrug resistance by microRNAs in anti-cancer therapyChemotherapy with cisplatin: insights into intracellular pH and metabolic landscape of cancer cells in vitro and in vivo.Biphasic ROS production, p53 and BIK dictate the mode of cell death in response to DNA damage in colon cancer cellsBERing the burden of damage: Pathway crosstalk and posttranslational modification of base excision repair proteins regulate DNA damage management.Inhibition of the Continuum of Radiation-Induced Normal Tissue Injury by a Redox-Active Mn Porphyrin.Hyper-phosphorylation of Sequestosome-1 Distinguishes Resistance to Cisplatin in Patient Derived High Grade Serous Ovarian Cancer Cells.Accumulation of prohibitin is a common cellular response to different stressing stimuli and protects melanoma cells from ER stress and chemotherapy-induced cell death.Platinum(IV)-nitroxyl complexes as possible candidates to circumvent cisplatin resistance in RT112 bladder cancer cells.Selenium potentiates the anticancer effect of cisplatin against oxidative stress and calcium ion signaling-induced intracellular toxicity in MCF-7 breast cancer cells: involvement of the TRPV1 channel.The Phytoestrogen Genistein Affects Breast Cancer Cells Treatment Depending on the ERα/ERβ Ratio.Involvement of cytochrome P450 in cisplatin treatment: implications for toxicity.Pim kinase inhibition sensitizes FLT3-ITD acute myeloid leukemia cells to topoisomerase 2 inhibitors through increased DNA damage and oxidative stress.A FANCD2/FANCI-Associated Nuclease 1-Knockout Model Develops Karyomegalic Interstitial Nephritis.
P2860
Q21090597-41A35155-0E8D-4940-8D7E-9595944A2004Q26750753-2C323B93-8DC3-46FB-A6EB-2A1667BD20C1Q26775475-8A5BAB85-1DAB-4342-BF28-57D724FBC469Q27334935-F6574813-1818-4A86-B9F8-373CBE4C93CFQ28072518-02D7BE1E-4DB5-4A5A-8C19-FA7B07CE54B2Q28075971-77EF5437-A13F-43F8-A32E-58608366C915Q28080615-65E3914E-4655-4001-9D33-507902037320Q28392665-CC1FFB2E-3B77-44EE-8797-54860E741998Q28393501-377A7CD8-34F4-4D24-8171-B0F9A7A7A25AQ28546838-2C29E6E1-3883-4A15-9A42-F7CDE1CEFA96Q29247912-CA00F3F4-8CC5-463B-80D8-175CC0C62DDEQ33591414-63E9D144-A85E-4FD5-999D-B3D48B9138D8Q34278299-DF803FB7-EC1E-44F0-B1E1-497880FC46FBQ34444812-BC9AC62C-4071-4933-BA23-C55A4514C571Q34582485-FAB330B6-7D85-41FD-B5C0-D6A7A0DC7405Q34960940-1432F7AB-3613-4AE4-9A3A-D77CAF6B0629Q35019531-325B75B7-C4D1-4DCB-B2B9-AFECBA78B0CAQ35440258-B5B59819-E488-4BD1-95FA-505E0BC1D813Q35744299-DB78B9BC-F9CF-460F-8C07-D91432600B34Q35750358-AD075A1B-0B9B-4FFB-88AB-5A27C154AB1FQ36153146-F2DD7868-0D58-4DBB-AE1E-77EBA91713F5Q36327667-44E02329-D743-4877-9026-529694C341B9Q36561564-2D36E05C-B68E-4B27-B931-EAD171FF6D43Q36573652-FB8C9430-72BB-4C02-B904-73D856999E11Q36951577-0EB99C4D-9F31-4516-AB01-049A07C5E361Q36983497-45C18B2C-123B-4C9A-81F3-86F41DA93594Q37582400-96CC6ADA-592A-42D5-9D53-504C6C759E7DQ37587311-1311CE4A-1F59-432F-811C-8B0399EB0F1BQ38615271-5CD541E5-6CCE-4467-9D26-3E88F7D0C0A1Q38630410-05890A7B-40E7-4A1A-BEA4-5BBC365ECBFFQ38669183-9C978CB8-9ACA-4A34-BB74-B0559D51DBD1Q38703100-B5FDFC06-C9A2-49BA-8DE3-DBC5DA45C103Q38705569-B5E2F97E-9233-42BB-8D28-F267EE397148Q38754109-DF031DF9-5EA7-4942-A37D-D657A949500BQ38764239-04C57970-C51A-426C-830B-BA051A536DCBQ38780004-8088000E-702E-46B2-9258-CFFDB5E5E333Q38861044-DBD1D108-2619-4529-8C16-032BB83C1A73Q39371239-CED76216-5420-476E-ABB3-A5F725C93A74Q39635459-500C3C47-73F8-4C36-8E55-055189A8A664Q39879248-27F79FE3-54C6-45BC-89B9-D4D907F4C6FB
P2860
Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Cisplatin induces a mitochondr ...... tus and bioenergetic functions
@ast
Cisplatin induces a mitochondr ...... tus and bioenergetic functions
@en
Cisplatin induces a mitochondr ...... tus and bioenergetic functions
@nl
type
label
Cisplatin induces a mitochondr ...... tus and bioenergetic functions
@ast
Cisplatin induces a mitochondr ...... tus and bioenergetic functions
@en
Cisplatin induces a mitochondr ...... tus and bioenergetic functions
@nl
prefLabel
Cisplatin induces a mitochondr ...... tus and bioenergetic functions
@ast
Cisplatin induces a mitochondr ...... tus and bioenergetic functions
@en
Cisplatin induces a mitochondr ...... tus and bioenergetic functions
@nl
P2093
P2860
P3181
P1433
P1476
Cisplatin induces a mitochondr ...... tus and bioenergetic functions
@en
P2093
Bryn Moore
Erica Werner
Natalya Degtyareva
Paul W Doetsch
Suresh S Ramalingam
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0081162
P407
P577
2013-01-01T00:00:00Z